Jean-François Viallard

19PUBLICATIONS
54CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityAllergyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 28, 2025
Efficacy and safety of dapsone in adult primary immune thrombocytopenia.

Marion Larue, Guillaume Moulis, Manuela Rueter

|Oct 30, 2024
Long-term follow-up of the STOPAGO study.

Adrien Cottu, Stéphanie Guillet, Jean-François Viallard

|Sep 30, 2024
Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies.

Margaux Soulard, Lionel Galicier, Nizar Mahlaoui

|Jan 24, 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.

Guillaume Moulis, Manuela Rueter, Aymeric Duvivier

|Jan 17, 2024
Influence of Splenomegaly and Splenectomy on the Immune Cell Profile of Patients with Common Variable Immunodeficiency Disease.

Jean-François Viallard, Marie Parrens, Patrick Blanco

Pageof 4